Aktis Oncology Inc (AKTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKTS | EVO | COLL | ||
| Company | Aktis Oncology Inc | Evotec Se | Collegium Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 20.93 | 3.29 | 34.29 | ||
| High | 21.48 | 3.30 | 34.47 | ||
| Low | 19.85 | 3.21 | 33.21 | ||
| Latest | 20.50 | 3.23 | 33.27 | ||
| Change | -0.33 | +0.08 | -1.04 | ||
| % Change | -1.58% | +2.54% | -3.03% | ||
| Volume | 294,900 | 164,700 | 253,800 | ||
| 20-Day Average Volume | 356,065 | 96,465 | 559,610 | ||
| Previous Close | 20.83 | 3.15 | 34.31 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.85 | 2.74 | 33.68 | ||
| 20-Day Raw Stochastic | 85.25% | 87.75% | 36.58% | ||
| 20-Day Relative Strength | 57.17 | 60.05 | 39.55 | ||
| Weighted Alpha | N/A | -14.10 | +6.02 | ||
| Today's Opinion | N/A | 40% Sell | 88% Sell | ||
| Previous Opinion | N/A | 40% Sell | 72% Sell | ||
| Last Month's Opinion | N/A | 88% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.91% since 04/14/26 | +3.53% since 04/14/26 | -6.65% since 04/14/26 | ||
| Low | 17.75 on 04/15/26 | 3.13 on 04/20/26 | 32.64 on 04/16/26 | ||
| High | 21.50 on 04/20/26 | 3.36 on 04/17/26 | 36.13 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | +15.82% since 03/20/26 | +32.92% since 03/20/26 | -6.12% since 03/20/26 | ||
| Low | 14.72 on 03/30/26 | 2.34 on 03/24/26 | 31.54 on 04/06/26 | ||
| High | 21.50 on 04/20/26 | 3.36 on 04/17/26 | 36.77 on 03/23/26 | ||
| 3-Month | |||||
| %Chg | +0.49% since 01/21/26 | -7.71% since 01/21/26 | -29.23% since 01/21/26 | ||
| Low | 14.72 on 03/30/26 | 2.31 on 03/13/26 | 31.54 on 04/06/26 | ||
| High | 23.36 on 01/22/26 | 3.82 on 02/03/26 | 49.31 on 02/05/26 | ||
| 6-Month | |||||
| %Chg | N/A since 01/09/26 | -19.45% since 10/21/25 | -5.91% since 10/21/25 | ||
| Low | 14.72 on 03/30/26 | 2.31 on 03/13/26 | 31.54 on 04/06/26 | ||
| High | 29.16 on 01/09/26 | 4.27 on 10/27/25 | 50.79 on 12/29/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,112,384 | 1,119,800 | 1,111,884 | ||
| Shares Outstanding, K | 53,403 | 355,492 | 32,407 | ||
| Annual Sales | 27,380,000 | 891,970,000 | 780,570,000 | ||
| Annual Net Income | -167,950,000 | -117,120,000 | 62,870,000 | ||
| Last Quarter Sales | 1,870,000 | 295,330,000 | 205,450,000 | ||
| Last Quarter Net Income | -15,138,000 | 15,870,000 | 16,960,000 | ||
| 60-Month Beta | N/A | 1.92 | 0.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | 2.04 on 02/26/26 | ||
| Latest Earnings Date | 06/29/26 | 11/05/25 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 5.21 | ||